Skip to main content

Influenza Archives

Cutting-edge research to be showcased in May

May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...

Read more


Flu boosts pneumococcal colonization

Mar. 27, 2014—Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.

Read more


VU testing vaccine against new flu threat

Sep. 19, 2013—Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring.

Read more


Controversial info release aids VUMC bird flu research

Sep. 5, 2013—Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin.

Read more


Vaccine researchers ready as new flu strain evolves

Aug. 22, 2013—A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China.

Read more


Flulapalooza vaccination event set for Sept. 25

Aug. 15, 2013—Vanderbilt University and Medical Center faculty, staff, students and volunteers will once again have the opportunity to be part of a mass flu vaccination event that two years ago more than doubled the current world record for the total number of vaccinations given in an eight-hour period.

Read more


Flulapalooza 3 is Sept. 25

Aug. 14, 2013—Flulapalooza 3 will be held Wednesday, Sept. 25, from 6 a.m. to 6 p.m. in a tent between Light Hall and the Veteran’s Administration Hospital.

Read more


Vanderbilt researchers work to balance flu vaccine debate

Apr. 4, 2013—Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.

Read more


Structural snapshot hints at new influenza approach

Feb. 21, 2013—A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.

Read more


Vaccination still key defense as flu season continues

Feb. 14, 2013—As is the case throughout the country, this year’s flu season in Middle Tennessee is hitting elderly people particularly hard.

Read more


Flu season’s rise highlights crucial role of vaccination

Jan. 17, 2013—While this year’s flu season appears to be slowing down in some parts of the country, we’re not out of the woods yet, caution officials at Vanderbilt University Medical Center.

Read more


Flu shot key to keeping yourself, your family, your patients safe

Dec. 13, 2012—As the number of influenza cases increases throughout Middle Tennessee, the Department of Infection Control and Prevention and the Occupational Health Clinic (OHC) are urging all faculty and staff to get an influenza vaccination.

Read more


Recent Stories from VUMC News and Communications Publications

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

Momentum

Sharon Seibert is among the more than 5,000 patients who have received a stem cell transplant at Vanderbilt-Ingram Cancer Center, which has one of the best survival rates in the nation and is at the forefront of new cellular therapies.

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

more